IL150564A0 - Preparation method of azithromycin dihydrate - Google Patents

Preparation method of azithromycin dihydrate

Info

Publication number
IL150564A0
IL150564A0 IL15056401A IL15056401A IL150564A0 IL 150564 A0 IL150564 A0 IL 150564A0 IL 15056401 A IL15056401 A IL 15056401A IL 15056401 A IL15056401 A IL 15056401A IL 150564 A0 IL150564 A0 IL 150564A0
Authority
IL
Israel
Prior art keywords
azithromycin
desmethyl
acetone
preparation
relates
Prior art date
Application number
IL15056401A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26870122&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL150564(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL150564A0 publication Critical patent/IL150564A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15056401A 2000-01-04 2001-01-04 Preparation method of azithromycin dihydrate IL150564A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17433000P 2000-01-04 2000-01-04
US22068100P 2000-07-25 2000-07-25
PCT/US2001/000364 WO2001049697A1 (en) 2000-01-04 2001-01-04 Preparation method of azithromycin dihydrate

Publications (1)

Publication Number Publication Date
IL150564A0 true IL150564A0 (en) 2003-02-12

Family

ID=26870122

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15056401A IL150564A0 (en) 2000-01-04 2001-01-04 Preparation method of azithromycin dihydrate

Country Status (9)

Country Link
US (1) US6586576B2 (de)
EP (1) EP1246831B1 (de)
AT (1) ATE388159T1 (de)
AU (1) AU2928701A (de)
CA (1) CA2396426A1 (de)
DE (1) DE60133083D1 (de)
IL (1) IL150564A0 (de)
PT (1) PT1246831E (de)
WO (1) WO2001049697A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
KR100431431B1 (ko) * 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
DE60209704T2 (de) 2001-05-22 2006-11-16 Pfizer Products Inc., Groton Neue kristallforme von azithromycin
ITMI20021209A1 (it) * 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB2395482A (en) * 2003-07-03 2004-05-26 Jubilant Organosys Ltd Process for preparing non-hygroscopic azithromycin dihydrate
BRPI0416535A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc processo de congelamento por vaporização empregando um extrusor para preparar composições de azitromicina de multiparticulado contendo preferivelmente um poloxámero e um glicerìdeo
RU2258070C1 (ru) * 2004-01-29 2005-08-10 Открытое акционерное общество "Акционерное курганское общество медицинских препаратов и изделий "Синтез" Способ получения азитромицина
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
WO2007029266A2 (en) * 2005-05-24 2007-03-15 Kopran Research Laboratories Ltd A process for preparing 9-deoxo-9a-aza-9a-homoerythromycin a
WO2007015265A2 (en) * 2005-05-24 2007-02-08 Kopran Research Laboratories Ltd A process for preparing 6,9-imino ether
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
EP2385825B1 (de) * 2008-11-07 2018-10-10 University of Connecticut Faktor-viii-formulierungen
CN102413826A (zh) 2009-03-13 2012-04-11 达·沃尔泰拉公司 用于消除革兰氏阴性菌的组合物和方法
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
WO2011015219A1 (en) 2009-08-06 2011-02-10 Shifa Pharmed Industrial Group Co. Process for the purification of azithromycin by separation from its thermal degradation products and/or isomers
CN104004037B (zh) * 2014-06-12 2016-10-19 宜春学院 黄芩苷及其酯的8-位甲胺类衍生物及其制备方法
CN105030704B (zh) * 2015-06-29 2018-09-07 石药集团欧意药业有限公司 阿奇霉素片剂及其制备方法
CN104910222B (zh) * 2015-06-29 2018-02-13 石药集团欧意药业有限公司 阿奇霉素新晶型化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
PT102130A (pt) 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina

Also Published As

Publication number Publication date
CA2396426A1 (en) 2001-07-12
WO2001049697A1 (en) 2001-07-12
AU2928701A (en) 2001-07-16
ATE388159T1 (de) 2008-03-15
PT1246831E (pt) 2008-03-28
EP1246831B1 (de) 2008-03-05
US6586576B2 (en) 2003-07-01
DE60133083D1 (de) 2008-04-17
US20010047089A1 (en) 2001-11-29
EP1246831A1 (de) 2002-10-09
EP1246831A4 (de) 2003-04-23

Similar Documents

Publication Publication Date Title
PT1246831E (pt) Método de preparação de di-hidrato de azitromicina
IL164404A0 (en) A process for producing sucralose and sucralose compositions prepared thereby
NZ594077A (en) Process for production of delta-9-tetrahydrocannabinol
TW331561B (en) Production of sucralose without intermediate isolation of crystalline sucralose-6-ester
PL364137A1 (en) Corrosion inhibitors for aqueous systems
LV12735A (en) Manufacture and pharmaceutical compositions thereof
SI1151007T1 (sl) Postopek za pripravo pripravka na osnovi fibrinogena in fibronektina in proteinski sestavki, ki jihlahko dobimo po tem postopku
ES2177178T3 (es) Procedimiento mejorado para la obtencion de precursores de insulina con puentes cistina correctamente unidos.
MXPA05001518A (es) Un igni-retardante y un metodo para la produccion del mismo.
WO2004027074A3 (en) Extraction, purification and conversion of flavonoids from plant biomass
UA89057C2 (ru) Способы получения полиморфных форм мезотриона и применение регулирования рн
AU7090601A (en) Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid
JP2002531365A5 (de)
EP0941999A3 (de) Herstellung von Azithromycindihydrat
IL162691A0 (en) Purification of onium hydroxides by electrodialsysis
AU6701300A (en) Method for the production of a solvent-free alpha- liponic acid
FR2864787B1 (fr) Procede de fabrication d'une solution de chlorure de sodium et d'hypochlorurite de sodium
ES2803213T3 (es) Procedimiento para la preparación de diosmina
DE602004024687D1 (de) 7-CARBOXYMETHYLOXY-3 , 4 , 5-TRIMETHOXYFLAVONMONOHYDRAT, HERSTELLUNGSiVERFAHREN DAFÜR UND SEINE VERWENDUNGEN
HRP20010083B1 (en) A process for the preparation of zofenopril calcium salt
AU2001273933A1 (en) A process for the preparation of highly crystalline sodium cefoperazone
WO2000053567A8 (en) Method for the production of serinol
Singh et al. The synthesis of 2, 3, 4, 6, 7-penta-O-methyl-d-glycero-l-manno-heptose and 2, 4, 6, 7-tetra-O-methyl-d-glycero-l-manno-heptose
ATE272643T1 (de) Verfahren zur herstellung eines reinen, pharmacopoiealgrad amorphes form von cefuroxim axetil
CN103421063B (zh) 一种合成吗啡-6-β-D-葡萄糖醛酸苷的方法